Back to dashboard
CommercialCoverageMedium impact

Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults

Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Blue Cross Blue Shield of Mississippi has updated their policy on hematopoietic cell transplantation for solid tumors in adults, confirming that both autologous and allogeneic transplants remain investigational (not covered) for a comprehensive list of solid tumor types including lung, colon, prostate, melanoma, and others. Prior authorization through Case Management is required for any covered transplant procedures.

Action Required

Action needed
Immediately: Billing team must ensure prior authorization is obtained through Blue Cross Blue Shield of Mississippi Case Management before scheduling any hematopoietic cell transplantation procedures. Verify that solid tumor transplants (lung, colon, rectal, pancreatic, stomach, esophageal, gallbladder, bile duct, renal cell, cervical, uterine, fallopian tube, prostate, nasopharyngeal, paranasal sinus, neuroendocrine, soft tissue sarcoma, thyroid, thymus, unknown primary, and melanoma cancers) are flagged as investigational/non-covered in billing system for BCBS Mississippi members.